Can those with mild traumatic brain injury (mTBI) be differentiated from non-head injured orthopaedic trauma controls by measuring brain wave activity? These are the preliminary data from MEGAbIT, a ...

Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, NE4 6BE, UK Correspondence to: Dr R Barber, Akenside Unit, Centre for the Health of the Elderly, Newcastle ...

Dr Dorothy Wade is Consultant health psychologist at Royal Free London NHS Foundation Trust. She has a PhD in health psychology and healthcare evaluation from University College London, where she is ...

Correspondence to Dr Hakan Ay, AA Martinos Center for Biomedical Imaging and Stroke Service, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown ...

Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK Objective: To perform a pilot trial of occupational therapy (OT) to optimise functional ...

Objective To test the hypothesis that Joint hypermobility and autonomic dysfunction are over-expressed within neurodevelopmental disorders. Joint hypermobility is a widespread poorly recognized ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting the upper and lower motor neurons. A key clinical feature of ALS is the absence of accurate, early-stage ...

OBJECTIVES To clarify whether different causative events (trauma, stroke, intracranial surgery), time of intervention, and treatment mode influence outcome, patients with fixed and dilated pupils ...

Correspondence to Dr Benedict Daniel Michael, University of Liverpool Institute of Infection and Global Health, Liverpool L69 3BX, UK; benmic{at}liv.ac.uk Clinicians are increasingly recognising ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Adult-onset leukodystrophies and genetic leukoencephalopathies comprise a diverse group of neurodegenerative disorders of white matter with a wide age of onset and phenotypic spectrum. Patients with ...

Identifying biomarkers of Alzheimer’s disease (AD) will accelerate the understanding of its pathophysiology, facilitate screening and risk stratification, and aid in developing new therapies.